Amlodipine Does NOT Lower Heart Rate
Amlodipine is not indicated for reducing heart rate and does not significantly affect heart rate in clinical practice. Amlodipine is a dihydropyridine calcium channel blocker that acts primarily as a peripheral arterial vasodilator to reduce blood pressure, but it has minimal to no effect on heart rate 1.
Mechanism and Cardiovascular Effects
Amlodipine works by inhibiting calcium influx into vascular smooth muscle, causing peripheral vasodilation and blood pressure reduction. Unlike non-dihydropyridine calcium channel blockers (diltiazem, verapamil), amlodipine does not have significant negative chronotropic effects 1. The FDA label explicitly states that chronic oral administration "did not lead to clinically significant changes in heart rate" in patients with angina 1.
Key Evidence:
- Electrophysiologic studies confirm amlodipine does not change sinoatrial nodal function or atrioventricular conduction 1
- Blood pressure reductions with amlodipine occur "without a significant change in heart rate or plasma catecholamine levels with chronic dosing" 1
- In clinical trials with angina patients, amlodipine therapy "did not alter electrocardiographic intervals" 1
Clinical Studies on Heart Rate
Multiple research studies have examined amlodipine's effect on heart rate:
- A study in healthy volunteers showed no change in heart rate responses during exercise despite therapeutic plasma concentrations 2
- Another exercise study found amlodipine caused only a modest increase in resting heart rate (from 65 to 70 bpm), but this was not clinically significant and post-exercise heart rate responses were unchanged 3
- In heart failure patients, amlodipine treatment did not affect heart rate, sympathetic nerve activity, or baroreflex control 4
- Ambulatory blood pressure monitoring studies showed amlodipine had no effect on heart rate over 24-hour periods 5
Appropriate Agents for Heart Rate Reduction
If heart rate reduction is your therapeutic goal, you should use:
First-line options:
- Beta-blockers (metoprolol, atenolol, bisoprolol, carvedilol) - these are the primary agents for heart rate control 6, 7
- Non-dihydropyridine calcium channel blockers (diltiazem, verapamil) - these have direct negative chronotropic effects 8, 7
Important distinction:
The pediatric pulmonary hypertension guidelines list bradycardia as a potential adverse effect of amlodipine 8, but this is listed as a class effect warning for all calcium channel blockers and does not reflect amlodipine's actual clinical profile. In practice, bradycardia is much more common with diltiazem than with dihydropyridines like amlodipine 8.
Clinical Caveat
While acute intravenous administration of amlodipine can transiently increase heart rate (due to reflex tachycardia from rapid vasodilation), chronic oral administration does not produce clinically meaningful heart rate changes 1. This makes amlodipine safe to use in combination with beta-blockers without additive bradycardic effects 1.
Bottom line: Choose beta-blockers or non-dihydropyridine calcium channel blockers (diltiazem/verapamil) if heart rate reduction is your therapeutic objective. Amlodipine is excellent for blood pressure control and angina management through afterload reduction, but it will not lower heart rate.